RxDoctor Payments Data

Eszter Varga

Family · Arlington, VANPI 1215368949

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 68 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$187
  • Supernus Pharmaceuticals, Inc.$167
  • Abbott$165
  • Lilly USA, LLC$118
  • Ironshore Pharmaceuticals Inc.$97
  • Exact Sciences$69
  • plus $477 from 14 others

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,280 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$57,312
Medicare patients
197
Services billed
674

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide42$86,075
OzempicSemaglutide32$61,115
JanuviaSitagliptin Phosphate32$42,931
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$26,316
FarxigaDapagliflozin Propanediol16$21,952
JardianceEmpagliflozin14$20,079
VyvanseLisdexamfetamine Dimesylate12$7,302
Albuterol Sulfate HfaAlbuterol Sulfate132$3,144
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,815
Lo Loestrin FeNorethindrone-E.Estradiol-Iron15$2,813
Atorvastatin Calcium308$2,493
Nano 2nd Gen Pen NeedlePen Needle, Diabetic28$2,407
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate21$2,186
Losartan Potassium170$1,761
Levothyroxine Sodium161$1,685

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$118$86,07542 claims
Novo NordiskOzempic$58$61,11532 claims
MerckJanuvia$46$42,93132 claims
GSKTrelegy Ellipta$16$26,31631 claims
AstraZenecaFarxiga$42$21,95216 claims
AbbVieLo Loestrin Fe$187$2,81315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,332 family providers in Virginia.

Other family in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →